Related by context. All words. (Click for frequent words.) 64 Sensipar R 64 Initiate Phase 63 Initiated Phase 63 PROCTOCORT R 62 Randomized Phase 62 Pivotal Phase 61 Neulasta R 61 PENTASA 61 AVONEX ® 61 initiated Phase Ib 61 Copegus ribavirin 61 hydrocortisone prescription 61 Commence Phase 61 LymphoStat B belimumab 61 Xeloda ® 61 dextromethorphan quinidine 61 Initiates Phase 60 Novel Oral 60 COLAZAL R 60 XAGRID 60 nausea dehydration dyspnea 60 Milestone Payment 60 Hycamtin ® 60 Argatroban 60 Million Milestone Payment 60 ps :# 60 Commences Phase 60 Soriatane R 59 equi analgesic doses 59 ZEFFIX 59 RITUXAN 59 Trelstar R 59 Recurring royalties 59 Confirmatory Phase 59 EMRG FRX CEN 59 Phase 2b Clinical Trial 59 Sensipar ® 59 Peg IFN 59 ITA Kawasaki ZX 59 Milestone Payments 58 Phase IIb Trial 58 evaluating satraplatin 58 % hydrocortisone acetate 58 palonosetron hydrochloride injection 58 topical antifungal steroid 58 Eur Arch 58 infliximab monotherapy 58 developing adecatumumab 58 NEUPOGEN R 58 MYoung Texas 58 Navelbine ® 58 COPEGUS R 58 Timolol ophthalmic solution 58 Crofelemer budesonide foam 58 XL# anticancer compounds 58 Ultane Sevorane 58 Fenoglide 58 MT# MEDI 58 Interferon alfa 57 Camptosar ® 57 BRoberts Baltimore 57 elotuzumab 57 vesicular monoamine transporter 57 VISICOL R 57 markets Testim ® 57 TMC# [002] 57 PegIFN 57 Receives Fast Track 57 2R 2RBI 57 MLN EUROS 57 Xibrom TM 57 Pruvel TM 57 Hydrochlorothiazide Tablets 57 Par Pharma 57 LGonzalez Arizona 57 fludarabine phosphate 57 docetaxel Taxotere R 57 refractory chronic lymphocytic 57 mg Tablets 57 Biaxin clarithromycin 57 SPRYCEL ® 57 Study Evaluating 57 pegylated interferon alpha 2a 57 Peginterferon alfa 2b 57 trastuzumab Herceptin R 57 evaluating T DM1 57 abstr 56 Initiates Phase II 56 ASoriano Texas 56 Banania Brittney 56 Pharma Merck Serono 56 Extended Release tablets 56 ketoconazole USP Gel 56 mg/#.# mg [003] 56 Increlex TM 56 IV Busulfex 56 J Antimicrob Chemother 56 + - Vulnerable 56 #.# subd [003] 56 BETHEL UNIV 56 Agenerase 56 Second Pivotal Phase 56 Vitaflo Scandinavia AB 56 AAG geldanamycin analog 56 Luveris R Ovidrel R 56 miconazole Lauriad 56 class anticancer quinolone 56 Successfully Completes Phase 56 Sanctura 56 Perifosine KRX 56 ESMO Accepted Abstract 56 metastatic hormone refractory 56 CARBATROL 56 R rilonacept Injection 56 TKB# 56 non nucleoside inhibitor 56 DOV Pharmaceutical 56 μg dose 56 TAB Treble 56 Gentamicin Surgical Implant 56 R roscovitine CDK cyclin 56 Pivotal Phase III 56 CONCORDIA COLLEGE 56 CFR #.#b 56 Amaryl R 56 Azactam 56 Cheltenham Saras 56 - + - [002] 56 WEIGHTED AVG 56 GlaxoSmithKline Requip 56 Ixempra 56 Zanaflex 55 platelet aggregation inhibitor 55 Ondansetron Orally Disintegrating Tablets 55 Pivotal Phase II 55 multicenter Phase 55 Andrea Frizell . 55 interferon gamma 1b 55 MGiles Atlanta 55 Recap NYM 55 Glucotrol XL 55 Testosterone MDTS ® 55 DIVIDEND OF 55 INSPIRE Trial Phase III 55 risedronate sodium tablets 55 assessing T DM1 55 Amlodipine Besylate Tablets 55 SFinley San Francisco 55 STRIANT 55 Freel Cincinnati 55 CIMZIA TM 55 Clin Orthop 55 All Timing Unofficial 55 pegylated interferon alpha 55 Non GAAP Gross Margin 55 PT Ctfs Series 55 Keppra ® XR 55 Actoplus Met 55 Benicar ® 55 Recap HOU 55 SUPPRELIN R LA 55 drug pipeline TAFA# 55 VONAGE HOLDINGS CORP. TABLE 55 dependent kinase inhibitor 55 Mln Private Placement 55 2b rbi 55 #/Aug 55 diabetes pills Januvia 55 JWilson Pittsburgh 55 sargramostim 55 AZX# Phase 55 Noncritical violations found 55 Aprovel R 55 Roche OTC RHHBY 55 :5 55 anagrelide hydrochloride 55 g trans fats 55 Risperidone Oral Solution 55 Matrix Phase 2b 55 Phase 2b Trial 55 GVAX ® 54 Vancocin R 54 Fitch Rates CWALT 54 Pravachol pravastatin 54 Kinesin Spindle Protein KSP 54 peginterferon alfa 2a Pegasys 54 polyunsat 54 REMICADE monotherapy 54 suppl #S 54 MOrdonez Detroit 54 novel synthetic PEGylated 54 FIRST TRANCHE AMT 54 Wellbutrin XL R 54 PRAVACHOL R 54 USD #.#bln [001] 54 dopamine partial agonist 54 HaRamirez Florida 54 R sorafenib tablets 54 Radford . 54 cancer neuroendocrine tumor 54 IV APAP 54 BENCHMRK 54 ASCO Accepted Abstract 54 Offsides h 54 Pentasa 54 DELMARVA CHRISTIAN 54 LIALDA MEZAVANT 54 please visit http:/www.vandapharma.com 54 BioMarin Genzyme LLC 54 BioSante Pharmaceuticals Announces 54 TriCor TRILIPIX 54 Recap NYY 54 BY GUILLERMO 54 TRI STATE UNIVERSITY 54 Pegasys peginterferon alfa 2a 54 Kertus Davis Chevrolet 54 therapeutically inactive prodrug 54 Cardene 54 PEG interferon 54 ALLEGRA ® 54 ThaiLin Semiconductor Corp. 54 * olmesartan medoxomil 54 Custirsen 54 Somatuline R Depot 54 low dose cytarabine 54 NCruz Texas 54 QUARTER = [009] 54 RAPTIVA 54 JKent Houston 54 Phase IIb Clinical Trial 54 AJackson Detroit 54 Losartan Potassium 54 AMORTIZATION 54 Zenvia ™ 54 Cytogen marketed 54 S1 S# [002] 54 novel emulsion formulation 54 Teveten 54 Dorzolamide 54 migraine headaches AZ 54 Somatuline Depot 54 THALOMID R 53 i NOTIFICATION OF 53 NDA Submission 53 Lodrane 53 TLK# 53 Consensus +#.# 53 evaluating Xcytrin 53 cinacalcet HCl 53 Ferlay J et al 53 Pruvel ™ 53 INTRODUCTION I. 53 Gabitril 53 ® bortezomib 53 Zegerid OTC 53 Gemzar ® 53 AdJones Baltimore 53 THEN BEGIN FALLING 53 PCRX 53 Omacetaxine 53 = -lushly decorated 53 polymer platinate 53 ACC2 53 ROWAN Katie 53 ABILIFY ® 53 Lung Cancer Trial 53 - -winger Colby Armstrong 53 QUARTER = [006] 53 Xcellerated T Cells 53 RAPTIVA R 53 CRGN 53 Immunotherapeutic 53 Bristol Myers Squibb Pravachol 53 Receive Milestone Payment 53 BORDER = 53 mso footer margin 53 AHill Toronto 53 Xcytrin R 53 SinuNase ™ 53 R#/MEM # 53 fexofenadine HCl 53 mg ethinyl estradiol 53 OLAF COLLEGE 53 Treximet ® 53 COMMENCED 53 Targretin capsules 53 ABILIFY R 53 Janssen AI 53 CEverett Texas 53 Recap BAL 53 pentadentate logo R 53 interferon alpha Severe 53 Phase Ib Clinical Trial 53 UNDIVIDED INTEREST 53 EUR #,#,#.# MATURING [002] 53 Locteron exclusively 53 relapsed refractory multiple myeloma 53 Phase III Pivotal 53 La Quotidienne 3 53 ZALBIN ™ 53 TVID 53 Angelini Labopharm 53 TRC# 53 successfully commercialize Iluvien 53 Recap CIN 53 1Q FY# representing 53 FOULS BY PERIOD 53 Arimidex anastrozole 53 registrational trial 53 ularitide 53 ViroChem Pharma Inc. 53 Recap TOR 53 nonsedating antihistamine 53 oral ridaforolimus 53 PrWilson Colorado 53 Cloretazine R VNP#M 53 Randomized Phase III 53 ONTAK 53 ELESTAT 53 oral contraceptives Loestrin 53 CORLUX CORT # 53 RESTORE CLI trial 52 #.#IP #H 52 VWells Toronto 52 novel orally inhaled 52 Aloxi injection 52 MetroGel R 52 Metres TURF 52 Non Dilutive 52 Adam LoGiudice 52 Eloxatin ® 52 Advicor R 52 DORYX 52 ARCALYST R 52 OPANA franchise 52 Fast Tracked Phase 52 fluticasone salmeterol 52 INVESTORS BID UP 52 NJ SALES TAX 52 ACCLAIM COPD 52 Azmacort R 52 Non GAAP Operating Margin 52 § #E 52 Phase Ib II 52 placebo controlled Phase 52 doxazosin 52 Receives Milestone Payment 52 Ottley Trevor . 52 Celgene Thalomid 52 FORADIL 52 INTEGRILIN ® 52 EChavez Oakland 52 Phase 1b Clinical Trial 52 HYZAAR 52 n#.# [002] 52 MAJOR INTERESTS IN SHARES 52 metastatic CRC 52 Asentar TM 52 OLEPTRO ™ 52 Qrtr 52 divalproex sodium 52 TKM ApoB 52 Phase IIa trials 52 palifosfamide Zymafos TM 52 LAWRENCE UNIVERSITY 52 Spectrum Pharmaceuticals Announces 52 VEGFR2 inhibitor 52 nalbuphine ER 52 R pegaptanib sodium 52 Empatic ™ 52 INEGY 52 MiCabrera Florida 52 DOVONEX 52 Aplidin R 52 Istalol 52 SAN DIEGO Helgren Oceanside 52 -Apparel Fabrics 52 alle di 52 DIFICID ™ 52 i#.rpm 52 SEK -#.# [003] 52 indapamide 52 TOPAMAX R 52 Deadlinepix 52 Pennsaid ® 52 CJones Atlanta 52 Targeted Chemotherapy 52 Pfizer Camptosar 52 Womacks Adjusted EBITDA 52 Noven Pharma 52 Snowbush Microelectronics 52 Xalatan 52 Favourable Changes total 52 Wellbutrin SR 52 PT S# 52 Fanapt iloperidone 52 ENZON 52 Pentacel R 52 rizatriptan 52 AJones Atlanta 52 BORDER = 0 52 highly purified pasteurized 52 Million Non Brokered 52 Pro forma EPS 52 Don Null 52 treatment naive genotype 52 ARCALYST ® 52 tramadol ER 51 REBETOL combination therapy 51 Rzeczpospolita pp. A1 51 Ditropan XL 51 Tritace R 51 Ultracet R 51 PREOS R 51 docetaxel prednisone alone 51 BPhillips Cincinnati 51 MOVIPREP R 51 Fortamet 51 Taclonex 51 neurogenic orthostatic hypotension 51 OvaRex R 51 Tiuxetan 51 MNOK #,# 51 HCD# [002] 51 pills Januvia 51 generation DACH Platinum 51 POL PRO 51 mso header 51 KGreene San Diego 51 Recap WSH 51 danoprevir 51 Infergen R 51 Fitch Rates CWMBS 51 ZALBIN 51 spud #-#-# drlg [003] 51 Xolegel 51 VANTAS R 51 midstage clinical 51 LIDODERM 51 LUCENTIS r 51 NON BROKERED PRIVATE PLACEMENT 51 BB HBP 51 RESPECTIVELY 51 IS COMPLETE 51 HOUSE Remains 51 TONNES OF 51 [014] 51 Naglazyme R 51 XL# SAR# 51 Europe entitled MINDSET 51 INTEGRILIN 51 Tekturna HCT 51 Kahalalide F 51 GlaxoSmithKline Tykerb 51 Private Equity Financing 51 Cetirizine Hydrochloride Tablets 51 AstraZeneca Symbicort 51 Noven Therapeutics 51 Non Dilutive Financing 51 - Adjusted EBITDA [001] 51 Doryx 51 SEK -#.# -#.# [002] 51 Auxilium Pharma 51 Nasdaq ETWC leading 51 Garth Tander Holden Commodore 51 XYREM 51 - NET INCOME [011] 51 dose escalation Phase 51 RAPID TRANSIT 51 Anti CD# Antibody 51 AZASITE 51 BTG plc 51 SHR VIEW 51 Zevalin R Ibritumomab 51 CGonzalez Colorado 51 RAPTIVA r 51 Humulin ® 51 Bryan Klimchak 51 metoprolol succinate 51 Benicar HCT 51 Presents Positive Preclinical 51 NASDAQ ALNY 51 Programmer Paradise segment 51 contracting activity W#P#Q 51 STRIANT ® 51 RETALIX LTD 51 include ClindaReach TM 51 Paul Dumbrell Holden 51 Lexiscan R 51 NET PROFITS 51 Eligard R 51 oncolytic virus therapies 51 Xanafide 51 La Quotidienne 51 MILLION FINANCING 51 Highlighted Matchups 51 Phase Ib clinical 51 unconsolidated joint 51 Fumapharm AG 51 NET CASH FLOW FROM 51 PLAVIX R 51 R hylan GF 51 LUCENTIS 51 mso bidi language 51 Ethyol 51 SSosa Chicago 51 alvespimycin 51 mso tstyle colband size 51 #mg q8h 51 PLAVIX ® 51 MILLION PRIVATE PLACEMENT 51 Vertex Pharma 50 BIOPHARMA 50 Frova R 50 UNDER PRESSURE DOWN 50 BioTie 50 Kory Deluca 50 income1 50 0 3First Period 1 50 mso tstyle rowband size 50 Billion Share Repurchase 50 Inc. NASDAQ TRMS 50 aflibercept 50 Inc. NASDAQ ZLCS 50 THALOMID 50 - Non Shane Germann 50 AVINZA 50 #.#/hr #hrs No 50 Migranal 50 Paxil CR TM 50 YMolina 50 BEFORE TAXES 50 TPIAO 50 BioGlue R 50 http:/events.fai.org 50 Biopharmaceuticals AG 50 RESTASIS 50 #.#/#.#m 50 Nipent R 50 Cetrotide R 50 MRamirez Boston 50 var arrMeta = 50 Miguel Tejada ss 50 CNH GLOBAL NV 50 #P [004] 50 Rocaltrol 50 Dana Windecker 50 MiCabrera Detroit 50 LifeVantage Announces 50 AGY Asia 50 Galderma SA 50 Interest Income Expense 50 MIVI III 50 CEPHEID 50 ARamirez Chicago 50 #/#/# DIAGNOS inc 50 Evoltra ® 50 Eligard ® 50 RESULTS CONFERENCE CALL PHONE 50 hoFH 50 Actimmune R 50 cathepsin K inhibitor 50 ACEON R 50 Nascobal R 50 Avail 1Sept 50 Megace R 50 AMEVIVE 50 ALN VSP Phase 50 Lipitor Plavix 50 Kyowa Kirin 50 FEET WATER 50 Bob Eberline 50 PI3K/Akt pathway inhibitor 50 DELATESTRYL 50 Proquin XR 50 JPY8 50 Pegylated interferon 50 EOquin TM 50 R epinastine HCl 50 opioid induced bowel dysfunction 50 totaled EUR#.# 50 Global Injectables 50 'S BUY RECOMMENDATION 50 Maddie Haroldson 50 = Adjusted [002] 50 IMPROVED TO 50 Taxotere docetaxel 50 JGuillen Kansas City 50 Avail 1May 50 Guides FY# Quick Facts 50 DILUTED SHARE 50 TEAM RESULTS 50 BCIRG 50 D PGAL 50 DOWNTREND CALL 50 Noninterest expense totaled 50 CSTL I. ORE MAN 50 BEPREVE 50 3Q FY# 50 NASDAQ ENZN 50 - - [036] 50 Noninterest Expense Noninterest expense 50 Taiho Pharmaceutical 50 Minisink Valley MV 50 Wireline adjusted EBITDA 50 Q3 YTD 50 Orthovisc R 50 Intangibles amortization 50 novel MetAP 2 50 CENTRAL PACIFIC FINANCIAL CORP. 50 TRACON Pharmaceuticals 50 Prd Time Team 50 IgG1 monoclonal antibody 50 Phase 1b 50 Kerry Voted Nay 50 # Fax +# [004] 50 UVIDEM 50 dose escalation clinical 50 netsales 50 Epivir 50 MAXY 50 Tiazac R 50 Vinny D' Ambrosio 50 ADVA OPTICAL NETWORKING 50 Normalized EPS 50 NASDAQ ACOR 50 AEscobar Milwaukee 50 - END PGP SIGNATURE 50 - Adjusted [017] 50 CREW CAB #.#L V6 50 ACQUIRED BY 50 millioncompared 50 Impax Laboratories Inc 50 torsemide ER 49 FROVA 49 JANUVIA JANUMET 49 Revises FY# Outlook 49 Ishpreet Bindra 49 Lexiscan ® 49 Acta Orthop 49 NET REVENUES 49 Cell Genesys GVAX 49 INTERACTIVE ENTERTAINMENT 49 Currency translation negatively impacted 49 Inc. www.micromet inc.com 49 OTHER EXPENSE 49 carboplatin chemotherapy 49 Q#/# EUR [002] 49 developing ostarine selective 49 Guides FY# FY# 49 - Non GAAP [002] 49 H1 NET PROFIT 49 confirmatory Phase III 49 HCV SPRINT 49 Backs FY# Forecast 49 Aeolus Pharmaceuticals Announces 49 Preotact ® 49 Segment PTOI 49 AEterna 49 Onyx Pharmaceuticals Announces 49 IS GOING BACK IN 49 BioGlue ® 49 Dave Lonis 49 John Klimacek 49 By TRACY RENCK 49 Tron Legacy uploads 49 SKILLED NURSING FACILITIES 49 DOrtiz Boston 49 RH Sergio Romo 49 Angio Seal TM 49 Systemic Delivery 49 PSMA ADC 49 Belinostat 49 Celgosivir 49 selectin antagonist 49 - - [113] 49 Nasdaq PGNX today 49 OSV newbuild program 49 Pro forma adjusted EBITDA 49 - - Total [072] 49 Megace ES 49 phase IIb 49 FOR FURTHER INFORMATION ABOUT 49 PHILIP MORRIS INTERNATIONAL INC. 49 Polyurethanes segment 49 Pulmozyme 49 CTI Squared 49 - - TotRobert Gisevius Jr. 49 Mycamine 49 SHOTS ON GOAL 49 EBITA amounted 49 - - [005] 49 #mo [001] 49 Home Properties HME 49 RESEARCH AND DEVELOPMENT 49 #mg capsules [001] 49 phase Ib 49 Simvastatin Tablets 49 BY SCOT ANDREW 49 Tom Mcgraw 49 Biaxin XL 49 SEK -# 49 SEK#.#m [001] 49 THE PUEBLO CHIEFTAIN 49 INTEGRILIN R eptifibatide Injection 49 ARB telmisartan 49 KVH Receives 49 CAPITAL TRUST 49 achieved CCyR 49 Engineered Material Systems 49 Cerep 49 PentaStaph 49 Advair HFA 49 Pfizer Sutent 49 Prochieve R 49 Maxipime 49 Cephalon NASDAQ CEPH 49 Glaxo Wellcome plc 49 bd div story 49 - Non GAAP [031] 49 Bayer HealthCare Onyx Pharmaceuticals 49 TRISENOX 49 ABELCET 49 Solazed 49 Kosan dependence 49 BY USED IN 49 #.#/diluted share 49 INDEBTEDNESS 49 ARDIS 49 THROUGHPUT 49 nine monthsended 49 Oxy ER 49 ridaforolimus 49 AUTO 5SPD 49 PT Ctfs 49 Scantron segment decreased 49 Polyphenon ® E 49 Motorhome Resorts Segment 49 VICTOR E1 49 clopidogrel bisulfate 49 NV Organon 48 GetGoal Phase III 48 Phase Ib study 48 Gaming Router 48 INCOME LOSS BEFORE INCOME 48 @ stolt.com 48 Recurring Adj 48 Viagra Cialis Accutane 48 SEASONALE R 48 #.#IP #H #R #ER 48 gemcitabine Gemzar R 48 6 Cyl 48 Phase IIb trials 48 -By Cliodhna McGowan 48 -1 -2 48 Captisol ® 48 Mtge PT Ctfs Series 48 Declares Dividend Quick Facts 48 LUMIGAN R 48 VANTAS 48 sevelamer hydrochloride 48 BRIM2 48 Exceptional Items 48 Akorn Strides 48 InKine 48 Orthovisc ® 48 Solzira 48 NPA GMANews.TV 48 Diastat 48 Drinks Americas Announces 48 Patrick Nann 48 % SINCE UPTREND 48 Nasdaq ETWC 48 #M approx [002] 48 IIb clinical trial 48 Wally Ostasz 48 Subphase 48 Discontinued operation 48 Transkaryotic Therapies TKTX 48 PLK1 SNALP 48 ft TW 48 BD Biosciences segment 48 Thalomid ® 48 CAPITAL BUDGET 48 Senior Subordinated Debentures 48 -inspecting fuselages 48 Pruvel 48 Zovirax ® 48 Epzicom 48 BY JORDAN LITE 48 Ellence 48 nephrotic syndrome NS 48 Eli Lilly Gemzar 48 Phase 1a 48 Cardiac Surgery Systems 48 StromaCel Inc. 48 Pro Forma Revenues 48 ZANAFLEX CAPSULES 48 EBITD 48 OLpur TM H2H 48 NGSX 48 YARD FREESTYLE 48 Lifts FY# Guidance 48 collaborator Bayer HealthCare 48 8 Cyl 48 CALGB # [002] 48 custirsen 48 CAPHOSOL R 48 Convertible Exchangeable Preferred Stock 48 IMiDs ® compound 48 By DENNIS DARROW 48 Increases Quarterly Distribution 48 INCOME LOSS FROM CONTINUING 48 kroner euro#.# [002] 48 CW POST 48 LaBarge Awarded 48 cholesterol reducer Zocor 48 Ortho Cept 48 # DOI 48 Lipitor Norvasc 48 Nasacort AQ 48 YARD FREESTYLE RELAY 48 please visit http:/www.atherogenics.com 48 XOPENEX Inhalation Solution 48 rpm SUSE LINUX 48 STEPHEN NOVER 48 Headline PBIT 48 FIRMAGON 48 Combunox 48 totaled USD#.#m 48 Lipofen R 48 Nexavar prescribing 48 EVERGREEN SOLAR 48 Engerix B 48 Dec# 0 48 George F. Dicamillo 48 CIP ISOTRETINOIN 48 FHLB borrowings decreased 48 HERCULES OFFSHORE INC. AND 48 COMVERGE INC. CONDENSED CONSOLIDATED 48 -Ignacio Galan 48 dutogliptin 48 adjusted2 48 JHP Pharmaceuticals 48 Proforma Proforma 48 AGGRASTAT 48 Kinsey Weydert 48 Benicar R 48 KADIAN ® 48 MARRIOTT REVENUES totaled 48 VA4 48 Million Unsecured 48 Unfavourable Changes 48 OVERALL RECORD 48 crazysharksman Castle Braai recommendations 48 paclitaxel Taxol ® 48 ACTONEL 47 Beautiful QWERTY keyboard 47 Segment adjusted OIBDA 47 Reimbursable revenues 47 Yashika kapoor 47 ITO Jeremy 47 Fully diluted EPS 47 Crinone 47 TURNOVERS BY PRD 47 ð ð 47 MC V. Entrées 47 Staff Writer mbaldwin@opubco.com Comments 47 GVAX R 47 TEAM . 47 REVENUE BONDS SERIES 47 Aleratec Part 47 Phase 2a trial 47 Interest Expense Net 47 ARUBA NETWORKS 47 EBITDAO 47 Orders Totaling Approximately 47 EUR#.#million 47 non nucleoside HCV 47 Prepaid churn 47 #-#-# COPYRIGHT 47 Restructuring Charges 47 Qtr Qtr Year 47 Partnered Brands segment 47 PRILOSEC OTC 47 barrels MMBbls 47 aspirin ibuprofen Advil Motrin 47 mg/m2 IV 47 Flu Cy 47 MSEK -#.# 47 www.kirrinresources.com CHF Investor Relations 47 Allegra ® 47 Medicis Pharmaceutical Corp 47 WAS CONTACTED 47 +#,# bbl 47 Anupreet Kaur 47 Nasdaq OPTR 47 PRE SURGE 47 Twinject R 47 Alanco Announces 47 TOLMAR Holding Inc. 47 BLU U R 47 Dynepo TM 47 Jorge Lorenzo Yamaha +#.# 47 - BalaSTEWART ENTERPRISES INC. AND 47 Powerball Jackpot Climbs 47 candidate REP# 47 Indevus Pharma 47 OLEPTRO TM 47 Softswitch Solution 47 LEVAQUIN ® 47 generic oral contraceptives 47 Phase Ia 47 Pretax Profit #,#,# #,#,# [001] 47 Esprit Pharma 47 STRUCTURE AND 47 Augmentin ES 47 Phase 2b study 47 Glaxosmithkline Plc 47 Discontinued Operations Income Loss 47 DAVID PAYNE 47 noninterest expense totaled 47 ASUR regulated 47 Mylan Bertek 47 EndoTAG TM -1 47 % unannualized 47 Assists HV -Ze'ev Boim 47 totaled SEK 47 Non GAAP Diluted EPS 47 FREE Domain 47 By Darrell Laurant 47 milligram capsule 47 contracting activity F# 47 BY TIM GANNON 47 Brovana 47 By JEFF TUCKER 47 Shubha Krishnappa 47 ADVENTRX Pharmaceuticals 47 EPS Excl 47 - TOTAL [019] 47 BY OWNER 47 bapineuzumab AAB 47 File #-# Apr. 47 IMPACT IMmunotherapy 47 II FLEXTRONICS INTERNATIONAL 47 CorePharma 47 Mega Millions Jackpot Grows 47 Mircette R 47 By Cheryl Mattix 47 Non Brokered Financing 47 Its presale estimate 47 octagam ® 47 Geomark 47 Pro forma EBITDA 47 Poonam Wadhwani 47 Residential Furnishings 47 SCHEDULED TO PREMIERE 47 ASSETS HELD FOR SALE 47 vinyl siding MORE 47 Rqd2 Castle Braai recommendations 47 By JEFF MASON 47 Rs #.# lacs [002] 47 Quinnova Pharmaceuticals Inc. 47 Housing Starts Plunge 47 weighted avg 47 Andy McElhannon 47 Volley Chicks 47 AstraZeneca Toprol XL 47 Dipartimento di Scienze 47 SuperStack 47 HealthStream Learning 47 increaseof 47 LIFO inventory decrement 47 9M FY# [001] 47 Fulton Brownwood Bulletin 47 Alexza Pharma 47 Wyeth Progenics 47 Gb SAS 47 marketable securities totaled 47 Product candidate Serada 47 Vivelle Dot ® 47 Sulonex TM 47 FARESTON R 46 totaled EUR#.#m 46 ofapproximately 46 CECO Environmental Announces 46 Approx. Market Cap 46 NASDAQ MOGN 46 ascompared 46 @ tbwa corporate.com 46 Akorn Strides LLC 46 Bryan Rosett 46 dacetuzumab SGN 46 specialty injectables 46 FORTESTA 46 JUVISTA 46 LUMIGAN 46 #E #E [003] 46 - - Total [007]